CardioVascular and Interventional Radiology

, Volume 16, Issue 2, pp 67–71

Segmental embolotherapy for hepatic cancer: Keys to success

Authors

  • Hideo Uchida
    • Department of RadiologyNara Medical University
    • Department of OncoradiologyNara Medical University
  • Naoki Matsuo
    • Department of RadiologyNara Medical University
    • Department of OncoradiologyNara Medical University
  • Hiroshi Sakaguchi
    • Department of RadiologyNara Medical University
    • Department of OncoradiologyNara Medical University
  • Noritada Nagano
    • Department of RadiologyNara Medical University
    • Department of OncoradiologyNara Medical University
  • Kiyoshi Nishimine
    • Department of RadiologyNara Medical University
    • Department of OncoradiologyNara Medical University
  • Hajime Ohishi
    • Department of RadiologyNara Medical University
    • Department of OncoradiologyNara Medical University
How I Do It

DOI: 10.1007/BF02602980

Cite this article as:
Uchida, H., Matsuo, N., Sakaguchi, H. et al. Cardiovasc Intervent Radiol (1993) 16: 67. doi:10.1007/BF02602980

Abstract

Transcatheter chemoembolization using Lipiodol (Lp) mixed with chemotherapeutic agents followed by Gelfoam particle injection only to the tumor-bearing hepatic segment (segmental Lp transcatheter hepatic artery embolization) (TAE) was applied to more than 100 patients with hepatocellular carcinoma and metastatic liver cancer. For segmental Lp-TAE, knowledge of the variations of intrahepatic arterial anatomy is important. Furthermore, the catheters and guidewires, volume of Lp, kinds and dose of chemotherapy, preparation of the mixture of Lp and chemotherapy (Lp-emulsion), method of injection of Lp-emulsion and Gelfoam particles, as well as the follow-up computed tomography examination are key items to the success of the procedure and are reviewed.

Key words

Segmental embolotherapy Intrahepatic arterial anatomy Superselective catheterization Hepatic cancer Lipiodol

Copyright information

© Springer-Verlag New York Inc 1993